Materialise NV
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.1
- Today's High:
- $6.18
- Open Price:
- $6.1
- 52W Low:
- $6.1
- 52W High:
- $11.97
- Prev. Close:
- $6.11
- Volume:
- 85934
Company Statistics
- Market Cap.:
- $360.90 million
- Book Value:
- 3.952
- Revenue TTM:
- $251.69 million
- Operating Margin TTM:
- 0.75%
- Gross Profit TTM:
- $128.77 million
- Profit Margin:
- 0.03%
- Return on Assets TTM:
- 0.29%
- Return on Equity TTM:
- 0.02%
Company Profile
Materialise NV had its IPO on 2014-06-25 under the ticker symbol MTLS.
The company operates in the Technology sector and Software-Application industry. Materialise NV has a staff strength of 2,439 employees.
Stock update
Shares of Materialise NV opened at $6.1 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $6.1 - $6.18, and closed at $6.11.
This is a 0% increase from the previous day's closing price.
A total volume of 85,934 shares were traded at the close of the day’s session.
In the last one week, shares of Materialise NV have slipped by -7.56%.
Materialise NV's Key Ratios
Materialise NV has a market cap of $360.90 million, indicating a price to book ratio of 2.2552 and a price to sales ratio of 2.4167.
In the last 12-months Materialise NV’s revenue was $251.69 million with a gross profit of $128.77 million and an EBITDA of $19.62 million. The EBITDA ratio measures Materialise NV's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Materialise NV’s operating margin was 0.75% while its return on assets stood at 0.29% with a return of equity of 0.02%.
In Q2, Materialise NV’s quarterly earnings growth was a positive 2546.7% while revenue growth was a positive 11.6%.
Materialise NV’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- -4.24
Its diluted EPS in the last 12-months stands at $-0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -4.24. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Materialise NV’s profitability.
Materialise NV stock is trading at a EV to sales ratio of 2.174 and a EV to EBITDA ratio of 14.2638. Its price to sales ratio in the trailing 12-months stood at 2.4167.
Materialise NV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $400.26 million
- Total Liabilities
- $98.33 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $2.12 million
- Dividend Payout Ratio
- 0%
Materialise NV ended 2024 with $400.26 million in total assets and $0 in total liabilities. Its intangible assets were valued at $400.26 million while shareholder equity stood at $233.43 million.
Materialise NV ended 2024 with $0 in deferred long-term liabilities, $98.33 million in other current liabilities, 4487000.00 in common stock, $-4951000.00 in retained earnings and $44.35 million in goodwill. Its cash balance stood at $136.29 million and cash and short-term investments were $136.29 million. The company’s total short-term debt was $17,466,000 while long-term debt stood at $49.82 million.
Materialise NV’s total current assets stands at $207.09 million while long-term investments were $3.93 million and short-term investments were $0. Its net receivables were $45.86 million compared to accounts payable of $22.79 million and inventory worth $16.01 million.
In 2024, Materialise NV's operating cash flow was $0 while its capital expenditure stood at $2.12 million.
Comparatively, Materialise NV paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $6.11
- 52-Week High
- $11.97
- 52-Week Low
- $6.1
- Analyst Target Price
- $12.11
Materialise NV stock is currently trading at $6.11 per share. It touched a 52-week high of $11.97 and a 52-week low of $11.97. Analysts tracking the stock have a 12-month average target price of $12.11.
Its 50-day moving average was $7.58 and 200-day moving average was $8.56 The short ratio stood at 1.08 indicating a short percent outstanding of 0%.
Around 394.6% of the company’s stock are held by insiders while 2165.9% are held by institutions.
Frequently Asked Questions About Materialise NV
Similar Industry Stocks (Software-Application)
Most Active
Top Gainers
Top Losers
About
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.